Science Explorer Back to mapMap
Discussion
Researcher · Levine Cancer Institute · United States

Nilanjan Ghosh

Nilanjan Ghosh publishes mostly in Pathology and Forensic Medicine, Oncology and Genetics, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and CAR-T cell therapy research.

ORCID 0000-0002-3848-6136 OpenAlex
World rank
#579,883
of 7,710,434 ranked researchers
Rank in United States
#199,598
of 1,627,098
Works
362
Citations
11k
Citations per work
30.0
h-index
43
i10-index 115Top 6.6% in Pathology and Forensic Medicine
Nilanjan Ghosh

What does Nilanjan Ghosh research?

Nilanjan Ghosh's work is mostly in Medicine (62%), Immunology and Microbiology (9%), Biochemistry, Genetics and Molecular Biology (5%).

Health Sciences: 223 works · 61.5% of their workMedicine: 223 works · 61.5% of their workPathology and Forensic Medicine: 80 works · 22.1% of their workOncology: 61 works · 16.9% of their workGenetics: 55 works · 15.3% of their workHematology: 26 works · 7.2% of their workEverything else: 90 works · 24.9% of their workLife Sciences: 49 works · 13.6% of their workImmunology and Microbiology: 31 works · 8.5% of their workImmunology: 31 works · 8.5% of their workBiochemistry, Genetics and Molecular Biology: 18 works · 5.1% of their workMolecular Biology: 18 works · 5.1% of their workTHEIR WORKNilanjan Ghosh362works
Life Sciences14%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine22361.5%
  2. Everything else9024.9%
    1. Immunology and Microbiology318.5%
    2. Biochemistry, Genetics and Molecular Biology185.1%
  1. 1Pathology and Forensic Medicine22% of their works
  2. 2Oncology17% of their works
  3. 3Genetics15% of their works
  4. 4Immunology8% of their works
  5. 5Hematology7% of their works
  6. 6Molecular Biology5% of their works

Research topics

Which keywords describe Nilanjan Ghosh's research?

The keywords of their largest research topics: Rituximab, Lymphoma, Classification, Molecular Profiling, Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations and CAR T Cells.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Rituximab3432 topics
  2. Lymphoma2942 topics
  3. Classification2011 topic
  4. Molecular Profiling2011 topic
  5. Prognostic Factors1943 topics
  6. Chronic Lymphocytic Leukemia1421 topic
  7. Genomic Aberrations1421 topic
  8. CAR T Cells931 topic
  9. Chimeric Antigen Receptor931 topic
  10. Cutaneous Lymphomas271 topic
  11. Mycosis Fungoides271 topic
  12. Acute Lymphoblastic Leukemia251 topic
  13. Childhood Cancer251 topic
  14. Bone Marrow Niche241 topic
  15. Hematopoietic Stem Cells241 topic
  16. Fc Receptors221 topic
  17. Therapeutic Antibodies221 topic
  18. BCR-ABL191 topic
  19. Imatinib191 topic

Where does Nilanjan Ghosh work?

Nilanjan Ghosh's main affiliation in the publication record is Levine Cancer Institute, United States.

How many publications and citations does Nilanjan Ghosh have?

OpenAlex counts 362 works and 10,853 citations for Nilanjan Ghosh, an h-index of 43, ranking #579,883 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Nilanjan Ghosh

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nilanjan Ghosh. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.